Table 1 Demographic and clinical characteristics of study participants (N = 135)
| Â | Number (%) of patients or median (IQR) |
|---|---|
Age, years | 66 (58–74) |
Sex, male | 91 (67.4) |
BMI, kg/m2 | 22.9 (20.6–26.0) |
Comorbidity | Â |
Malignancy | 66 (48.9) |
Diabetes | 41 (30.4) |
Chronic obstructive pulmonary disease | 16 (11.9) |
Chronic kidney disease | 10 (7.4) |
Cerebrovascular disease | 8 (5.9) |
Chronic liver disease | 8 (5.9) |
Congestive heart failure | 7 (5.2) |
Connective tissue disease | 2 (1.5) |
Clinical status at ICU admission | Â |
Need for mechanic ventilation | 59 (43.7) |
Need for vasopressor support | 70 (51.9) |
Severity of illness | Â |
SAPS3 score | 55 (47–63) |
APACHE II score | 24 (20–30) |
SOFA score | 9 (7–11) |
Laboratory findings | Â |
CRP, mg/dL | 12.5 (5.9–24.8) |
Lactic acid, mmol/L | 2.9 (2.0–4.4) |
Procalcitonin, ng/mL | 6.06 (0.85–25.18) |
IL-6, pg/mL | 228 (65–807) |
Platelet count, 103/μL | 135 (59–214) |
Albumin, g/dL | 2.9 (2.6–3.2) |
Total bilirubin, mg/dL | 1.1 (0.7–2.5) |
Creatinine, mg/dL | 1.3 (0.8–1.9) |